Eli Lilly (LLY) financial statements

+249.8%since 2007
FY2025 revenue
$65.2B▲ +44.7%
FY2025 net income
$20.6B▲ +94.9%
FY2025 diluted EPS
$22.95▲ +96.0%
FY2025 free cash flow
$9.0B▲ +138.6%

Eli Lilly income statement

Eli Lilly income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue65,17945,04334,124
Pretax income25,73112,6806,554
Net income20,64010,5905,240
Diluted earnings per share22.9511.715.80

Eli Lilly balance sheet

Eli Lilly balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents7,2683,2682,819
Total assets112,47678,71564,006
Total liabilities (derived)85,94164,44353,143
Total equity26,53514,27210,864
Long-term debt40,86828,52718,321

Eli Lilly cash flow statement

Eli Lilly cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow16,8138,8184,240
Capital expenditure-7,841-5,058-3,448
Free cash flow (derived)8,9723,760792
Dividends paid-5,384-4,680-4,069
Share repurchases-4,108-2,500-750

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended30 Sep 202630 Jun 202631 Mar 202631 Dec 2025
Revenue (derived)24,39722,97419,79919,292
Net income (derived)6,4517,0957,3966,638
Diluted earnings per share7.227.948.26n/a
Operating cash flow (derived)11,39710,6905,3333,225
Total assets148,072142,283116,576112,476

Eli Lilly major shareholders

Eli Lilly major shareholders
HolderShare of classSharesFiled
LILLY ENDOWMENT INC10.1%96,016,97816 April 2025
LILLY ENDOWMENT, INC.9.6%90,066,97819 October 2026
Vanguard Capital Management6.5%61,295,6051 May 2026
THE PNC FINANCIAL SERVICES GROUP, INC.5.4%51,153,8377 February 2025

Eli Lilly 10-K and SEC filings

Eli Lilly 10-K and SEC filings
FiledFormTypeDescription
29 October 202610-QQuarterly reportQuarterly report
29 October 20268-KCurrent reportCurrent report
5 August 202610-QQuarterly reportQuarterly report
5 August 20268-KCurrent reportCurrent report
20 May 20268-KCurrent reportCurrent report
7 May 20268-KCurrent reportCurrent report
30 April 202610-QQuarterly reportQuarterly report
30 April 20268-KCurrent reportCurrent report

Common questions

What was Eli Lilly's revenue in fiscal 2025?

Eli Lilly reported $65.2 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 44.7% from fiscal 2024.

What was Eli Lilly's net income in fiscal 2025?

Eli Lilly reported net income of $20.6 billion for fiscal 2025, the year ended 31 December 2025, up 94.9% from fiscal 2024. Diluted earnings per share were $22.95.

What was Eli Lilly's free cash flow in fiscal 2025?

Eli Lilly had $9.0 billion in free cash flow in fiscal 2025. Operating cash flow was $16.8 billion and capital expenditure was $7.8 billion.

What were Eli Lilly's total assets at the end of fiscal 2025?

Eli Lilly reported total assets of $112.5 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Eli Lilly history do I get?

Every account gets the full history, annual and quarterly, with first reported values and as of dates.